A FIRST-IN-CLASS, AGNOSTIC, HOST-DIRECTED PRECISION MEDICINE TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROME

$3,421,180FY2025Defense Health AgencyDOD

Xfibra, Inc., Del Mar CA

Investigators